The news directly mentions Nutrien (NYSE:NTR) and the lowered price target by JP Morgan analyst Jeffrey Zekauskas. The Neutral rating suggests that the analyst does not expect significant short-term price movement. However, the lowered price target may have a slight negative impact on investor sentiment, but it is not expected to cause a major price change in the short term.